Sciensus

Medical adherence is a critical challenge in healthcare, but the way patients do (or don’t) take their medicine is just one aspect of their healthcare journey. To improve outcomes, we must look beyond simple adherence and consider patients' lifestyles, behaviours, and influences. At Sciensus, our patient support programs (PSPs) offer a holistic approach, combining digital and in-person support. These programs provide valuable insights into adherence trends and barriers, showing that optimal support extends beyond the clinical setting. Using this approach, Sciensus continues to work to improve patient health outcomes. Learn more about how hybrid digital and patient services can help by reading our recent white paper: https://lnkd.in/esQP5NYj #Insights #PatientSupportProgrammes #PSPs #HealthOutcomes #MedicalAdherence

At Sciensus, we value learning and development of our teams. We're thrilled to announce the success of our brand-new internal leadership programme. Congratulations to all participants for their dedication and hard work, we are looking forward to seeing the positive impact you'll make. #Leadership #TeamDevelopment #Sciensus #LifeSciences

'Drug launch excellence needs a hybrid solution, combining digital patient support with human touch services'. Katie Duncalf, MSc, talks about the benefits to Pharma of creating a successful patient support solution at the Pharmaceutical Launch Excellence Summit in London last week. She discusses the 5 key steps for a successful patient support solution: 1. Understanding the patient journey 2. Building patient support 3. Creating Connected Care with the healthcare ecosystem 4. Generating Evidence 5. Continuing to measure, optimise and evolve the programme Katie emphasises how a patient-centric approach is imperative to driving adherence and improving patient health outcomes. To find out how Sciensus can enhance your patient support solution, visit: https://lnkd.in/ecUBxiwv #Pharma #DigitalSolutions #PatientAdherence #PharmaceuticalExcellence

Katie Duncalf, MSc, Head of Digital Commercialisation and Partnerships, took the stage at the Pharmaceutical Launch Excellence Summit in London today to discuss the critical challenges Pharma faces in achieving successful launches. Her presentation, "Digital Patient Engagement: The New Currency of Brand Success," showcased how innovative patient engagement and support services are transforming the industry and driving brand success. Katie shared how these strategies can: - Overcome launch barriers - Drive early adoption and adherence - Ensure market access success - Create a competitive advantage - Optimise commercial performance Discover how Sciensus Digital+ solutions can support your brand launch: https://lnkd.in/ecUBxiwv #Pharma #DigitalTools #PharmaceuticalExcellence IQPC R&D

Last week, our new CEO, Christian Tucat, visited our European offices to connect with the teams and gain insights into our operations. Tina Lupberger, Managing Director, shared: "The team was thrilled to welcome Christian so early in his journey with Sciensus. His visit in just his second week shows his commitment to understanding our market and business model. The Town Hall was particularly impactful, offering a fantastic opportunity for the team to hear directly from Christian about his early thoughts for the future of Sciensus." Christian looks forward to meeting more colleagues, learning about our work, and building relationships to drive Sciensus forward. #CEO #Sciensus #Switzerland #ScienceOfUs #LifeSciences

We’re thrilled to announce our participation in the Pharma Launch Excellence Summit on December 3rd and 4th. Katie Duncalf, MSc, Head of Digital Commercialisation and Partnerships, will be speaking on Digital Patient Engagement: The New Currency of Brand Success on the 3rd December at 2pm. Katie will delve into how digital tools can: • Enhance patient adherence to medication and have a significant impact on brand performance • Drive brand loyalty and real-world evidence generation • Improve healthcare provider satisfaction and loyalty We look forward to seeing you there! If you’d like to book a meeting with our team, email: patientinsights@sciensus.com #PharmaSummit #DigitalTools #PatientEngagement #PharmaLaunchExcellenceSummit

Sciensus provides ongoing support and outcome monitoring for patients and their caregivers. Our Patients Support Programs (PSP) consist of digital and/or human interventions delivered face-to-face or remotely by highly qualified Healthcare professionals (HCPs) across the whole of Europe. They enhance health outcomes and provide an opportunity to capture Patient and Clinician Reported Outcomes to generate Real-World Data. To find out more visit: https://lnkd.in/eHCGnfVk #RareDiseases #OrphanDrugs #Biotechs #PatientSupportPrograms

We had the pleasure of welcoming and hearing from our new CEO, Christian Tucat, during several town halls held in our UK offices last week. By way of a very interactive Q&A session, Christian candidly shared his insights, business vision and priorities for the months ahead, whilst meeting and greeting the hundreds of colleagues who attended the town halls. Christian also toured Sciensus’ facilities across the country and was given a comprehensive overview of the business and services we provide. It’s an exciting new chapter for Sciensus as we officially welcome Christian to the team. #CEO #Sciensus #ScienceOfUs

For biotech companies seeking to bring a new rare disease treatment to market in Europe, there can be many obstacles to overcome. More companies are now turning to expanded access programs (EAPs) to get these life-saving drugs to patients who often have no other treatment options. Drawing on over 30 years of experience in managing medications for rare and ultra-rare diseases, we’ve identified five key steps biotechs must follow to ensure a successful EAP in Europe. Learn more here https://lnkd.in/eWZuB7cg #RareDiseases #OrphanDrugs #Biotechs #ExpandedAccessPrograms

We are proud to announce that Sciensus has earned the prestigious National Equality Standard (NES) accreditation! This is a significant milestone in our journey to becoming a leader in Equality, Diversity, and Inclusion (EDI). At Sciensus, diversity is a core value and one that drives innovation and excellence in everything we do. Sciensus’ NES accreditation highlights our ongoing commitment to building a working environment where everyone can thrive and do their best work regardless of background. To learn more about what this accreditation means for us, visit: https://lnkd.in/eZkNquBp #Diversity #Inclusion #Equality #NES #NationalEqualityStandard #Sciensus #LifeSciences #ScienceOfUs